Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Parikh

Showing results (41-50 of 614) with videos related to

Pageof 62
Sort By:
Future Microbiology|August 24, 2012
Pretreatment HIV-1 drug resistance is strongly associated with virologic failure in HIV-infected patients receiving partly active antiretroviral regimensUrvi M Parikh, John W Mellors
Seminars in Nephrology|April 18, 2016
Mitochondria in Acute Kidney InjuryKenneth M Ralto, Samir M Parikh
Current Opinion in HIV and AIDS|December 5, 2024
Long-acting preexposure prophylaxis: early data on roll-out in the United StatesCatherine A Koss, Urvi M Parikh
Kidney International|December 11, 2020
Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1αAmanda J Clark, Samir M Parikh
The Journal of the Association of Physicians of India|August 17, 2006
Family history and pedigree charting--a simple genetic tool for Indian diabeticsShashank R Joshi, Rakesh M Parikh
Current Opinion in HIV and AIDS|June 28, 2022
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?Urvi M Parikh, John W Mellors
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
HIV-1 drug resistance resulting from antiretroviral therapy far exceeds that from pre-exposure prophylaxisUrvi M Parikh, John W Mellors
Journal of the Royal College of Surgeons of Edinburgh|February 17, 1999
Ankle fractures in diabeticsM Parikh, N Slater, C Walker
European Urology|January 1, 1995
Precautions and complications in the use of the urolume wallstentA M Parikh, E J Milroy
Current Opinion in HIV and AIDS|December 4, 2015
Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?Urvi M Parikh, John W Mellors
Pageof 62

Showing results (41-50 of 614) with videos related to

Sort By:
Pageof 62
Future Microbiology|August 24, 2012
Pretreatment HIV-1 drug resistance is strongly associated with virologic failure in HIV-infected patients receiving partly active antiretroviral regimensUrvi M Parikh, John W Mellors
Seminars in Nephrology|April 18, 2016
Mitochondria in Acute Kidney InjuryKenneth M Ralto, Samir M Parikh
Current Opinion in HIV and AIDS|December 5, 2024
Long-acting preexposure prophylaxis: early data on roll-out in the United StatesCatherine A Koss, Urvi M Parikh
Kidney International|December 11, 2020
Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1αAmanda J Clark, Samir M Parikh
The Journal of the Association of Physicians of India|August 17, 2006
Family history and pedigree charting--a simple genetic tool for Indian diabeticsShashank R Joshi, Rakesh M Parikh
Current Opinion in HIV and AIDS|June 28, 2022
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?Urvi M Parikh, John W Mellors
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
HIV-1 drug resistance resulting from antiretroviral therapy far exceeds that from pre-exposure prophylaxisUrvi M Parikh, John W Mellors
Journal of the Royal College of Surgeons of Edinburgh|February 17, 1999
Ankle fractures in diabeticsM Parikh, N Slater, C Walker
European Urology|January 1, 1995
Precautions and complications in the use of the urolume wallstentA M Parikh, E J Milroy
Current Opinion in HIV and AIDS|December 4, 2015
Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?Urvi M Parikh, John W Mellors
Pageof 62